Short answer
agilon health, inc. (AGL) filed an 8-K current report with the SEC on August 5, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Press release announces agilon health financial results for Q2 and first half of fiscal 2026.
agilon health, inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Press release announces agilon health financial results for Q2 and first half of fiscal 2026
- Results cover the three and six months ended June 30, 2026
- Investor focus: operating performance, guidance and cash position in Exhibit 99.1
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue rose 7% to $1.495B, while net income reached $18M versus a $104M loss, marking a major profitability inflection
- Medical margin improved to $197M from negative $53M, supported by favorable claims development and medical cost trends
- Adjusted EBITDA increased to $70M from negative $83M, demonstrating operating leverage despite 10% lower platform membership
- Membership fell 10% to 549,000, reflecting market exits and profitability-focused contracting, creating a growth constraint despite stronger economics
- Full-year guidance increased: revenue $5.775B-$5.860B, medical margin $465M-$505M, and Adjusted EBITDA $75M-$95M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other agilon health, inc. 8-K filings
Get the next AGL 8-K as it lands
Follow AGL for push alerts, or ask the research agent what this filing means.